Coal India invites bids for third phase of drilling mines in Mozambique
Taking forward its plans to develop mines in Mozambique, state-owned Coal India Ltd (CIL) has invited bids for the third phase of drilling in the African nation.
CIL said on its website that the company invites expression of interest (EoI) "for 3rd phase drilling inclusive of making access & preparation of site, water carting for drilling etc in Licenses area nos 3450 L & 3451L, Moatize Coalfield, Tete Province, Mozambique".
"In order to establish coal resource base, Coal India Africana Limitada (CIAL), a subsidiary of Coal India Ltd, plans to continue exploration...through outsourcing. Bids are invited from the interested bidders for the...job," it said.
CIL had earlier informed an inter-ministerial panel that the drilling of blocks in Mozambique had started in June, 2013. The selection of agency for the further drilling of 30,000 metre was completed in May, 2013.
The panel reviews the performance of maharatna firms, including Coal India.
The first stage of drilling of the mines had been completed in May last year. The contract for initial drilling was awarded in November 2012.
CIAL had won 5-year licence for exploration and development of mines in Mozambique in August, 2009.
Two coal blocks -A1 and A2- at Motaize, in Tete Province of Mozambique, are spread over 200 sq km.
CIL had registered its own subsidiary CIAL in mid-2009
Coal Minister Sriprakash Jaiswal had earlier said that the acquisition of coal mines overseas should be done in an aggressive manner to meet India's energy requirements.
In order to tide over the shortages of the fossil fuel, the government is also proposing to import coal.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.